About US
Nanorobotics for healthcare
Who we are
We are a pioneering medical hardware company specializing in the fabrication, deployment, and navigation of nanorobots within living systems.
Our patented technology platform enables the precise guidance of nanorobots for targeted drug delivery and microsurgical therapeutics, laying the foundation for the next generation of precision healthcare.
Born inside a research lab. Built for global healthcare.
Theranautilus emerged from pioneering nanorobotics research at the Centre for Nano Science and Engineering (CeNSE), IISc Bengaluru. We were founded on a simple belief: many diseases remain untreated because existing therapies cannot precisely target the affected tissue.
Our team developed a platform of nanorobotic technologies and magnetic navigation systems capable of accessing microscopic environments inside the human body. Today, we are advancing applications across oral healthcare, antimicrobial resistance, targeted drug delivery, and cancer theranostics.
Countries with IP Coverage
TRL-5
Vision
Mission
TIMELINE
Demonstration of Theranautilus technology to German Chancellor Friedrich Merz. Selected among India’s Top 10 innovative startups to showcase technology before Narendra Modi.
- Development of CalBots for treatment of dental hypersensitivity.
- IADR Innovation in Oral Care Award.
- Tata Transformation Prize in Healthcare.
- TRL-5 achieved.
- Recognised among India’s Top DeepTech startups through NASSCOM Emerge 50.
- BIRAC Biotechnology Ignition Grant awarded.
- Major international patent publication.
- World’s first demonstration of nanorobotics for root canal disinfection and targeted elimination of resistant bacteria.
- AWS Grand Challenge and DST NIDHI PRAYAAS recognition.
- National Start-up Award presented by the President of India.
- International patent portfolio expands.
Theranautilus founded to translate nanorobotics research into healthcare solutions.
First demonstrations of nanorobot navigation inside living cells.
Successful demonstration of biocompatible nanorobots operating in blood-like environments.
First breakthrough publication demonstrating controlled propulsion of magnetic nanostructures.
Foundational research in magnetic nanorobotics begins at Indian Institute of Science.
What Next
Human Clinical Trials
Global Regulatory Approvals
Commercial Deployment
Expansion into Oncology & Precision Medicine
Our team
Prof. Ambarish Ghosh
Dr. Debayan Dasgupta
Dr. Shanmukh Srinivas
Prajwal B Hegde
Satish Kumar Subramani
Sreelakshmi Meloth
Dr. Roshini Killada
our advisors
Dr. Bruce Lieberthal
Muttu Ozcan
